Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
TUSC2 is a highly conserved lung cancer candidate gene. Additionally we are shipping Tumor Suppressor Candidate 2 Proteins (3) and Tumor Suppressor Candidate 2 Kits (1) and many more products for this protein.
Showing 10 out of 44 products:
Human Polyclonal TUSC2 Primary Antibody for ELISA, WB - ABIN1533546
Kondo, Ji, Kamibayashi, Tomizawa, Randle, Sekido, Yokota, Kashuba, Zabarovsky, Kuzmin, Lerman, Roth, Minna: Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells. in Oncogene 2001
FOXP1 (show FOXP1 Antibodies), TP53INP1 (show TP53INP1 Antibodies), TNFAIP3 (show TNFAIP3 Antibodies), and TUSC2 were identified as miR (show MLXIP Antibodies)-19a targets.
The therapeutic activity of TUSC2 could extend the use of erlotinib to lung cancer patients with wildtype EGFR (show EGFR Antibodies).
TUSC2P and TUSC2 3'-UTR (show UTS2R Antibodies) expression inhibits cell proliferation, survival, migration, invasion and colony formation, and increases tumor cell death. TUSC2P and TUSC2 3'-UTR (show UTS2R Antibodies) bind to miRNAs and arrest their functions, leading to increased TUSC2 translation.
The tumor suppressor gene TUSC2 (FUS1) sensitizes NSCLC to the AKT (show AKT1 Antibodies) inhibitor MK2206 in LKB1 (show STK11 Antibodies)-dependent manner.
RNA sequence elements in FUS1 (show FUS Antibodies) UTRs that regulate FUS1 (show FUS Antibodies) protein express were identified.
Absence of tumor suppressor FUS1 (show FUS Antibodies) protein expression is associated with bone and soft tissue sarcomas.
Data show that the recombinant FUS1 (show FUS Antibodies) plasmid has been successfully cloned, which allows highly efficient FUS1 (show FUS Antibodies) expression in E.coli strain Rosetta (DE3)2 plys.
The goal of this study was to analyze possible involvement of TUSC2 in malignant pleural mesothelioma.
Myristoylation is required for Fus1 (show FUS Antibodies)-mediated tumor-suppressing activity and suggest a novel mechanism for the inactivation of tumor suppressors in lung cancer.
These results suggest that miR (show MLXIP Antibodies)-378 enhances cell survival, tumor growth, and angiogenesis through repression of the expression of two tumor suppressors, Sufu (show SUFUH Antibodies) and Fus-1 (show FUS Antibodies).
Fus1 achieves its protective role in inflammation, autoimmunity, and cancer via the regulation of mitochondrial calcium and calcium-coupled parameters.
This gene is a highly conserved lung cancer candidate gene. No other information about this gene is currently available.
tumor suppressor candidate 2
, PDGFA associated protein 2
, PDGFA-associated protein 2
, fus-1 protein
, fusion 1 protein
, lung cancer candidiate, FUS